From regulatory complexity to manufacturing hurdles to investor pressure, CGT drug developers face a uniquely demanding path to market. The 2026 Cell and Gene Therapy Summit, a premier one-day event in Boston on March 26, brings together over 170 industry leaders to tackle these challenges head-on.
This year's agenda includes a keynote from Flagship Pioneering's CTO, patient advocacy, panels on drug development strategy and CGT investment, and a new poster session. Whether you're a startup founder or a CMC director at a large pharma, there's something in this summit that applies directly to your program.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.